Orexigen Therapeutics (OREX)
Orexigen Therapeutics Income Statement
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Income | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Revenue | 0.857M | 0.857M | 0.857M | 0.857M | 1.828M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cost of Revenue | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Gross Profit | 0.857M | 0.857M | 0.857M | 0.857M | 1.828M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Research & Development Expense | 6.80M | 1.543M | 1.539M | 3.131M | 6.567M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Selling, General, & Admin. Expense | 4.512M | 3.632M | 3.907M | 5.204M | 6.759M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation & Amortization | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Operating Interest Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Operating Income (Expense) | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Operating Expenses | 11.31M | 5.175M | 5.446M | 8.335M | 13.33M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Income | -10.46M | -4.318M | -4.589M | -7.478M | -11.50M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non-Operating Income | 0.041M | 0.011M | 0.009M | -0.09M | -0.105M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Pretax Income | -10.41M | -4.307M | -4.58M | -7.568M | -11.60M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Provision for Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income after Tax | -10.41M | -4.307M | -4.58M | -7.568M | -11.60M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity In Affiliates | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income Before Extraordinaries & Disc. Operations | -10.41M | -4.307M | -4.58M | -7.568M | -11.60M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Investment Gains/Losses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Income/Charges | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income from Discontinued Operations | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Income | -10.41M | -4.307M | -4.58M | -7.568M | -11.60M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Earnings Per Share Data | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Average Shares to compute diluted EPS | 65.99 | 48.27 | 48.08 | 48.08 | 47.87 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Average Shares used to compute basic EPS | 65.99 | 48.27 | 48.08 | 48.08 | 47.87 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Basic net | -0.16 | -0.08 | -0.10 | -0.16 | -0.24 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Diluted net | -0.16 | -0.08 | -0.10 | -0.16 | -0.24 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
